Learn more

NOVELOS THERAPEUTICS INC

Overview
  • Total Patents
    22
About

NOVELOS THERAPEUTICS INC has a total of 22 patent applications. Its first patent ever was published in 1996. It filed its patents most often in United States, African Regional Industrial Property Organization and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are MONDOBIOTECH AG, PROXIMAGEN GROUP LTD and SHANGHAI INST OF CELL BIOLOGY.

Patent filings per year

Chart showing NOVELOS THERAPEUTICS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kozhemyakin Leonid A 11
#2 Balazovsky Mark Borisovich 9
#3 Kozhemyakin Leonid Andreevich 7
#4 Kozhemyakin Andrei Leonidovich 6
#5 Balasovski Mark B 5
#6 Balazovski Mark B 3
#7 Kozhemyakin Andrew L 3
#8 Pazoles Chris 1
#9 Vulfson Evgeny 1
#10 Huang Qihong 1

Latest patents

Publication Filing date Title
US2011064828A1 Treatment of metastatic tumors and other conditions
US2007142267A1 Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
EP1365789A1 Compounds comprising disulfide-containing peptides and nitrogenous bases, and medical uses thereof
AP2001002147A0 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis.
US6312734B1 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
US6251857B1 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
EP0869809A1 Oxidized glutathione as cytokine and hemopoietic factor endogenous production enhancer
AP9801260A0 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof.